Author: Mary-Louise Hoffman|| Date Published: June 30, 2022
The U.S. government is procuring up to 405 million COVID-19 vaccine doses from a partnership between Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) under a $3.2 billion firm-fixed-price contract.
The Department of Health and Human Services said Wednesday it expects to receive the initial doses for both adult and pediatric use in the fall.
“Vaccines have been a game-changer in our fight against COVID-19, allowing people to return to normal activities knowing that vaccines protect from severe illness,” said Xavier Becerra, secretary of HHS and a previous Wash100 Award winner.
The Biden administration plans to use a portion of reallocated funds from pandemic response efforts to pay for orders from Pfizer.
HHS collaborated with the Department of Defense on the procurement.
A Food and Drug Administration advisory panel recommended the use of a component targeting the SARS-CoV-2 Omicron variant in the national booster vaccination initiative.
War Data Platform enables standardized data for agentic AI applications Advana modernization includes financial management and application migration Explore AI,…
Noblis MSD has won a five-year, single-award IDIQ contract to provide end-to-end engineering services for the Network Integration Engineering Facility…
